Identification and characterization of stemlike cells in human esophageal adenocarcinoma and normal epithelial cell lines

Journal of Thoracic and Cardiovascular Surgery

Volumn 144, Issue 5, 2012, Pages 1192-1199

  Zhao, Ronghua ^a   Quaroni, Luca ^b   Casson, Alan G ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b PAUL SCHERRER INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACHAETE SCUTE COMPLEX HOMOLOG 2; ALPHA6 INTEGRIN; CD71 ANTIGEN; CISPLATIN; FLUOROURACIL; MESSENGER RNA; TRANSCRIPTION FACTOR MASH1; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; ASCL2 PROTEIN, HUMAN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; G PROTEIN COUPLED RECEPTOR; LEUKOCYTE ANTIGEN; LGR5 PROTEIN, HUMAN; TRANSFERRIN RECEPTOR; TUMOR MARKER;

ARTICLE; CANCER STEM CELL; CARCINOGENICITY; CELL CULTURE; CHEMOSENSITIVITY; CLONOGENESIS; COLONY FORMATION; CONTROLLED STUDY; EPITHELIAL CELL LINE; ESOPHAGEAL ADENOCARCINOMA; FLOW CYTOMETRY; HET-1A CELL LINE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; JH ESOAD1 CELL LINE; OE33 CELL LINE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPHEROID CELL; WESTERN BLOTTING; XENOTRANSPLANTATION; ADENOCARCINOMA; ANIMAL; CELL PROLIFERATION; DRUG EFFECT; DRUG RESISTANCE; DRUG SCREENING; EPITHELIUM CELL; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; MULTICELLULAR SPHEROID; NUDE MOUSE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; TRANSGENIC MOUSE; TUMOR CELL LINE; TUMOR VOLUME;

ADENOCARCINOMA; ANIMALS; ANTIGENS, CD; ANTINEOPLASTIC AGENTS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; DRUG RESISTANCE, NEOPLASM; EPITHELIAL CELLS; ESOPHAGEAL NEOPLASMS; FLOW CYTOMETRY; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA6; MICE; MICE, NUDE; MICE, TRANSGENIC; NEOPLASTIC STEM CELLS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, TRANSFERRIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPHEROIDS, CELLULAR; TIME FACTORS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85027936195     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2012.08.008     Document Type: Article

References (25)

1. Merlo, L.M.F., Shah, N.A., Li, X., Blount, P.L., Vaughan, T.L., Reid, B.J., et al. A comparative survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma. Cancer Prev Res 3 (2010), 1388–1397.
2. O'Brien, C.A., Kreso, A., Jamieson, C.H.M., Cancer stem cells and self-renewal. Clin Cancer Res 16 (2010), 3113–3120.
3. Keysar, S.B., Jimeno, A., More than markers: biological significance of cancer stem cell-defining molecules. Mol Cancer Ther 9 (2010), 2450–2457.
4. Dalerba, P., Dylla, S.J., Park, I.K., Liu, R., Wang, X., Cho, R.W., et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 104 (2007), 10158–10163.
5. Gutierrez-Gonzalez, L., Deheragoda, M., Elia, G., Leedham, S.J., Shankar, A., Imber, C., et al. Analysis of the clonal architecture of the human small intestinal epithelium establishes a common stem cell for all lineages and reveals a mechanism for the fixation and spread of mutations. J Pathol 217 (2009), 489–496.
6. Croagh, D., Thomas, R.J.S., Phillips, W.A., Kaur, P., Esophageal stem cells: a review of their identification and characterization. Stem Cell Rev 4 (2008), 4261–4268.
7. Barbera, M., Fitzgerald, R.C., Cellular origin of Barrett's metaplasia and oesophageal stem cells. Biochem Soc Tran 38 (2010), 370–373.
8. Grotenhuis, B.A., Dinjens, W.N.M., Wijnhoven, B.P.L., Sonneveld, P., Sacchetti, A., Franken, P.F., et al. Barrett's oesophageal adenocarcinoma encompasses tumor-initiating cells that do not express common cancer stem cell markers. J Pathol 221 (2010), 379–389.
9. Rockett, J.C., Larkin, K., Darnton, S.J., Morris, A.G., Matthews, H.R., Five newly established oesophageal carcinoma cell lines: phenotypic and immunological characterization. Br J Cancer 75 (1997), 258–263.
10. Stoner, G.D., Kaighn, M.E., Reddel, R.R., Reseau, J.H., Bowman, D., Naito, Z., et al. Establishment and characterization of SV40 T-antigen immortalized human esophageal epithelial cells. Cancer Res 51 (1991), 365–371.
11. Alvarez, H., Koorstra, J.B.M., Hong, S.M., Boonstra, J.J., Dinjens, W.N., Foratiere, A.A., et al. Establishment and characterization of a bona fide Barrett esophagus-associated adenocarcinoma cell line. Cancer Biol Ther 7 (2008), 1753–1755.
12. Qiang, L., Yang, Y., Ma, Y.J., Chen, F.H., Zhang, L.B., Liu, W., et al. Isolation and characterization of cancer stem like cells in human glioblastoma cell lines. Cancer Lett 279 (2009), 13–21.
13. Chiou, S.H., Yu, C.C., Huang, C.Y., Lin, S.C., Liu, C.J., Tsai, T.H., et al. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 14 (2008), 4085–4095.
14. Hu, Y., Smyth, G.K., ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 347 (2009), 70–78.
15. van de Loosdrecht, A.A., Beelen, R.H.J., Ossenkoppele, G.J., Broekhoven, M.G., Langenhuijsen, M.M.A.C., A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia. J Immunol Methods 174 (1994), 311–320.
16. Bobryshev, Y.V., Freeman, A.K., Botelho, N.K., Tran, D., Levert-Mignon, A.J.M., Lord, R.V.N., Expression of the putative stem cell marker Musashi-1 in Barrett's esophagus and esophageal adenocarcinoma. Dis Esophagus 23 (2010), 580–589.
17. Zhang, X., Komaki, R., Wang, L., Fang, B., Chang, J.Y., Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus. Clin Cancer Res 14 (2008), 2813–2823.
18. Huang, D., Gao, Q., Guo, L., Zhang, C., Jiang, W., Li, H., et al. Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines. Stem Cells Dev 18 (2009), 465–473.
19. 6 and CD71. Biochem Biophys Res Commun 367 (2008), 256–263.
20. Terunuma, A., Kapoor, V., Yee, W.G., Udey, M.C., Vogel, J.C., Stem cell activity of human side population and alpha 6 integrin-bright keratinocytes defined by a quantitative in vivo assay. Stem Cells 25 (2007), 664–669.
21. Lorenz, K., Rupf, T., Salvetter, J., Bader, A., Enrichment of human beta 1/ alpha 6 bri/CD71 dim keratinocytes after culture in defined media. Cells Tissues Organs 189 (2009), 383–390.
22. Croagh, D., Phillips, W.A., Redvers, R., Thomas, R.J.S., Kaur, P., Identification of candidate murine esophageal stem cells using a combination of cell kinetic studies and cell surface markers. Stem Cells 25 (2007), 313–318.
23. Jubb, A.M., Chalasani, S., Frantz, G.D., Smits, R., Grabsch, H.I., Kavi, V., et al. Achaete-scute like 2 (ascl2) is a target of Wnt signalling and is upregulated in intestinal neoplasia. Oncogene 25 (2006), 3455–3457.
24. Stange, D.E., Engel, F., Longerich, T., Koo, B., Koch, M., Delhomme, N., et al. Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain. Gut 59 (2010), 1236–1244.
25. Dessein, A.F., Stechly, L., Jonckheere, N., Dumont, P., Monte, D., Leteurte, E., et al. Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells. Cancer Res 70 (2010), 4644–4654.